DREAMM-11, Part 2: Japanese phase I trial of belantamab mafodotin combination therapies in relapsed/refractory multiple myeloma
2024 · International Journal of Hematology · 0 citations
https://doi.org/10.1007/s12185-024-03889-8
Toyo University(JP)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
4
Papers
25
Citations
2
h-index
2
i10-index
Ryuichi Fukushima is an academic researcher from Toyo University. The author has contributed to research in topics: bioluminescence and chemiluminescence research & Polysaccharides and Plant Cell Walls & Fungal Biology and Applications. The author has an h-index of 2, co-authored 4 publications.
Click to start Chat